This year we will extend our programme to consider other special populations. Speakers from industry, academia and clinical practice will join those from regulatory bodies to offer their perspectives and advice on the latest developments in the regulation of medicines for children at national and European level. The event will also encourage thinking about the requirements and issues for the development of medicines for use in other groups such as the elderly and women, including during pregnancy.